Infantile hemangioma in a V2 distribution: Treatment with nadolol
Infantile hemangiomas are common benign tumours of infancy affecting up to 10% of children. They are typically not present at birth but undergo a rapid proliferation stage and then plateau in growth before resolving spontaneously. Recently, beta-blockers have been favoured over systemic corticostero...
Main Authors: | Mariah Giberson, Robert Hayes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2015;volume=4;issue=1;spage=135;epage=136;aulast=Giberson |
Similar Items
-
Infantile Hemangioma Treated with Oral Propranolol: Case Presentation
by: Raufi N, et al.
Published: (2021-08-01) -
Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers
by: Aoife Naughton, et al.
Published: (2021-07-01) -
Oral atenolol versus propranolol in the treatment of infantile hemangioma: A systematic review and meta-analysis
by: Swapnil Annasaheb Pattanshetti, et al.
Published: (2022-01-01) -
Antiangiogenic potential of beta-blockers in the context of juvenile hemangioma treatment
by: Vl. V. Dubensky, et al.
Published: (2019-07-01) -
Comparison of the Effectiveness of Topical and Oral Beta Blockers in the Treatment of Childhood Hemangiomas
by: Kerim Faruk YÜKSEL, et al.
Published: (2023-12-01)